Concourse Financial Group Securities, Inc. Neuro Sense Therapeutics Ltd. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q1 2025
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding NRSN
# of Institutions
12Shares Held
195KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY50.5KShares$77,7710.0% of portfolio
-
Meitav Dash Investments LTD40KShares$61,6000.0% of portfolio
-
Xtx Topco LTD London, X033.7KShares$51,9070.0% of portfolio
-
Commonwealth Equity Services, LLC17.3KShares$26,5650.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.9KShares$24,4390.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $18M